A role for VEGF as a negative regulator of pericyte function and vessel maturation.
about
The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid.VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complexInteractions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesisHistone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNAHigh content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligationIP-10 induces dissociation of newly formed blood vesselsGuidance molecules in lung cancerVascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesRegulation of stem cell differentiation in adipose tissue by chronic inflammationFibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses MetastasesOxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivoMural cell associated VEGF is required for organotypic vessel formationThe ever-expanding role of HIF in tumour and stromal biologyExploring the tumor microenvironment with nanoparticlesAngiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- miceEngineering of a Biomimetic Pericyte-Covered 3D Microvascular NetworkPar-4: a new activator of myosin phosphataseLack of Cyp1b1 promotes the proliferative and migratory phenotype of perivascular supporting cellsBlood vessels as targets in tumor therapyPerivascular-like cells contribute to the stability of the vascular network of osteogenic tissue formed from cell sheet-based constructsPrimary xenografts of human prostate tissue as a model to study angiogenesis induced by reactive stromaIntegrins in cancer: biological implications and therapeutic opportunitiesAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Systems biology of pro-angiogenic therapies targeting the VEGF systemVascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation.Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells.In vitro microvessels for the study of angiogenesis and thrombosis.Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy.Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.The therapeutic promise of the cancer stem cell concept.Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edemaAnimal models of choroidal and retinal neovascularization.Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomasLong-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.
P2860
Q22000600-738A2FEE-CECE-4046-987F-4610337D871AQ24293027-18D91C32-0D84-4A4E-AC6B-C2FB178C6F2CQ24299293-01268E92-FCE8-486C-9BC3-E0537A58FF23Q24306661-8F0AF35C-8C7F-4635-BA59-BCACE68D78F9Q24311672-D38FD72A-F61A-4D99-AE5E-7EB80C491442Q24314328-62696F61-0557-4504-B380-19E08604416FQ24598659-0A510078-1E21-4C5E-A4DE-03D27E02057FQ26781833-F2165763-7D9F-4CE6-8589-D5E92925E9FAQ27016629-5C18C052-05A7-482F-8346-B51130567893Q27028193-65E6A3D0-1236-4071-B4E2-5C94AE525DEDQ27312628-A06E82C9-A28E-4210-ABF1-BF921037B3AEQ27320392-21D0295C-C2CB-42B3-9478-343A18F907FFQ27348757-CB9B1821-7552-442E-92B9-C491E9DCFE7AQ28079015-EEB594E0-BB31-4709-AF40-B78CEDAE3C42Q28082374-7E626FBF-F2BD-4573-9689-B09285BF2CFFQ28510099-09FD70CC-68DE-4177-B945-CB25044E3445Q28546737-E757C328-A70A-4687-AF08-DE8B37D7AAA1Q28573207-D5655B73-75D7-4123-8855-6F4070F296A0Q28585382-606109AF-5673-4910-80D3-80C87F947794Q28590737-6045DBEF-7EAA-4916-8CD6-612DA746D3BCQ28729038-DCDD76D7-CE00-4B03-9782-9A9F897F80C7Q28732327-3EF8B5AC-28B7-4975-BEF2-966B65B5B74FQ29614536-CA1CB1B0-F0FE-492A-A23B-60DC6EC57BB4Q30399006-711BDACF-B258-450A-A997-F3D579D60608Q30430112-90585C9E-2C2B-417F-BB3F-8780E7277CA9Q30469815-9BF2D030-DEBD-4A5B-9640-B9ECA08F9A13Q30471456-E61134B0-BAC0-4211-A3A7-FD1E374AF2E7Q30492193-944E075C-207C-4E64-9483-44981170F94EQ30495328-A03CC0AA-0A56-424D-BC79-C8291CA2C40AQ30519206-8931C013-0680-4619-B2F5-FB8B300A22B7Q30579125-866F04D0-2C02-4D5E-8B18-BAD04A875692Q30941105-2465F247-046D-4864-8D26-165505D8610AQ30945205-F420599A-B9E9-43F3-B811-455522E771F1Q33559711-08EB4365-6272-4B43-B77B-6DD9F3D46031Q33563100-E4345D22-AD8A-48C8-A376-3C6992836E6CQ33582933-1CD72A53-68E3-46E7-9D5A-BDB84ABC3C8EQ33597254-B02B5C29-CCE0-4114-91E0-8B0B401FFF10Q33627325-133273D5-04B6-460A-822E-3C5F0B50F657Q33640270-B864AD9F-A701-4249-95EA-F5D0F77A81A0Q33665623-891B7973-3571-4DA1-87ED-B9AEB8510098
P2860
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@en
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@nl
type
label
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@en
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@nl
prefLabel
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@en
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@nl
P2093
P2860
P356
P1433
P1476
A role for VEGF as a negative regulator of pericyte function and vessel maturation.
@en
P2093
Christian Stockmann
David A Cheresh
David J Shields
Eric Murphy
Jianhua Huang
Joshua I Greenberg
Lea Scheppke
Lisette M Acevedo
Niren Angle
Randall S Johnson
P2860
P2888
P304
P356
10.1038/NATURE07424
P407
P577
2008-11-09T00:00:00Z
P5875
P6179
1049771857